12 Biggest Mid-Day Gainers For Wednesday - Acasti Pharma (NASDAQ:ACST)

Vitae Pharmaceuticals Inc VTAE shares climbed 158.5 percent to $20.94. Allergan plc AGN and Vitae Pharmaceuticals reached an agreement by which the former would buy the latter for $21.00 a share in cash.
Biostar Pharmaceuticals Inc BSPM shares surged 66.8 percent to $3.42. Biostar shares have dropped 54.24 percent over the past 52 weeks, while the S&P 500 index has gained 8.91 percent in the same period.
Sarepta Therapeutics Inc SRPT gained 25.1 percent to $32.01. Dr. Ron Farkas has left the U.S. Food & Drug Administration, people familiar with the matter told Benzinga. Farkas was the most vocal critic of Sarepta's eteplirsen, although there were other FDA members who agreed there was little efficacy for the drug.
StemCells Inc STEM shares rose 23.9 percent to $1.62. StemCells shares have tumbled 78.59 percent over the past 52 weeks, while the S&P 500 index has increased 8.91 percent in the same period.
Acasti Pharma Inc ACST shares gained 23.6 percent to $1.56 after the company reported positive CaPre Omega-3 bridging study data.
Morgans Hotel Group Co. MHGC rose 21.5 percent to $2.15 as the company disclosed that it has received a revised takeover proposal of $2.75 per share.
Red Lion Hotels Corporation RLH shares gained 12.2 percent to $7.90. Red Lion Hotels reported the purchase of Vantage Hospitality Group.
Exelixis, Inc. EXEL climbed 6.3 percent to $13.08 after the company disclosed that the EC has approved CABOMETYX tablets for the treatment of advanced renal cell carcinoma following VEGF-targeted therapy.
Arctic Cat Inc ACAT rose 5.4 percent to $14.46. Wunderlich upgraded Arctic Cat from Sell to Hold.
Asterias Biotherapeutics Inc AST shares gained 5.4 percent to $3.88 after the company reported positive efficacy data in patients with complete cervical spinal cord injuries treated with AST-OPC1.
At Home Group Inc. HOME shares rose 4.7 percent to $13.03. At Home Group reported Q2 earnings of $0.13 per share on sales of $188.4 million. The company expects FY17 earnings of $0.53 to $0.56 per share on revenue of $738 million to $750 million. Guggenheim Securities upgraded At Home Group from Neutral to Buy.
Herbalife Ltd. HLF shares rose 4.5 percent to $62.53 following Carl Icahn comments at the Delivering Alpha conference Tuesday afternoon.

Market News and Data brought to you by Benzinga APIs